Children with spastic cerebral palsy : aspects of muscle activity and botulinum toxin a treatment
Author: Tedroff, Kristina
Date: 2009-02-06
Location: Skandiasalen, Astrid Lindgrens Barnsjukhus, plan 1
Time: 09.00
Department: Institutionen för kvinnors och barns hälsa / Department of Women's and Children's Health
View/ Open:
thesis.pdf (1.139Mb)
Abstract
Backgound: Cerebral Palsy (CP) is a heterogeneous disorder in which
movement and posture are always affected. Spasticity is one of the most
common symptoms. A spastic muscle prevents normal motor behaviour and is
believed to cause secondary contractures. Other motor symptoms include
central dyscoordination causing defects in coordination and excecution of
motion and excessive co-contraction in antagonist muscles. Muscle
activity in antagonist and adjacent muscles during voluntary movements
such as maximum voluntary isometric contraction (MVIC) is not completely
understood in children with CP nor in children with typical development
(TD). Despite a lack of strong evidence from randomised controlled trials
and little long-term data, intramuscular injections with botulinum toxin
A (BoNT-A) for treatment of increased muscle tone in children with CP has
become increasingly popular over the last decade.
Aims: The aims of the thesis were to compare the patterns of muscle activation during MVIC in lower extremity muscles and determine whether children with CP have more co-activity than TD children. A further aim was to write a comprehensive review on BoNT-A treatment with recommendations for future research. Further aims were to evaluate the effect of early BoNT-A treatment in toddlers with CP, and to prospectively evaluate any long-term effects of BoNT-A on muscle tone and joint range of motion (ROM) in the lower extremities of children with CP.
Methods/Results: Children with diplegic and hemiplegic CP and TD were assessed with surface EMGs. It was found that children with CP display greater variability in muscle onset order, shorter latencies to onset of other muscles than the intended muscle and twice as much co-activity in both antagonist and adjacent muscles, during MVIC compared to TD children. Ninety-four children with CP were prospectively followed for a maximum of 3 years and 7 months during which time they received a maximum of eight injections per muscle of BoNT-A. Outcome measurements included muscle tone and joint range of motion (ROM). BoNT-A injections reduced long-term spasticity in all muscle-groups examined: the gastrocnemius, hamstring, and adductor muscles. Improvement in ROM, however, was only significant after the first injection; after further injections, joint ROM was reduced. Children with CP, under 2 years of age at study start, participated in a randomized trial which compared the effects of one year of early BoNT-A treatment in the gastrocnemius muscle combined with a daily stretching program to a stretching program alone. The effects on ankle and knee ROM, muscle tone in ankle and knee flexors, gross motor function measure (GMFM) and pediatric evaluation of disability inventory (PEDI) were evaluated at one year and at 3.5 years after study commencement. Gait was evaluated with 3D-gait analysis at 5 years of age. Early treatment with BoNT-A significantly increased knee joint ROM and although not significantly, also increased ankle joint dorsiflexion in the BoNT-A group after 1 year. Children in the control group experienced significantly reduced joint ROM at both joint levels at 3.5 years after study commencement. No differences in GMFM or PEDI scores or 3D-gait data were detected comparing the groups.
Conclusions: The activation of muscles differs between children with CP and children with TD when performing a voluntary movement and children with CP express twice as much co-activity. Early BoNT-A intervention in toddlers with CP seems to influence muscle tone and contracture development also after 3.5 years. The effect on gait development remain inconclusive.When BoNT-A treatment in older children (mean age 5.5y at treatment start) is evaluated this suggests that BoNT-A can be effective in reducing muscle tone over a longer period, but not in preventing development of contractures in spastic muscles. The dissociation between the effects on muscle tone and ROM indicates that development of contractures is not coupled to increased muscle tone alone, but might be caused by other mechanisms.
Aims: The aims of the thesis were to compare the patterns of muscle activation during MVIC in lower extremity muscles and determine whether children with CP have more co-activity than TD children. A further aim was to write a comprehensive review on BoNT-A treatment with recommendations for future research. Further aims were to evaluate the effect of early BoNT-A treatment in toddlers with CP, and to prospectively evaluate any long-term effects of BoNT-A on muscle tone and joint range of motion (ROM) in the lower extremities of children with CP.
Methods/Results: Children with diplegic and hemiplegic CP and TD were assessed with surface EMGs. It was found that children with CP display greater variability in muscle onset order, shorter latencies to onset of other muscles than the intended muscle and twice as much co-activity in both antagonist and adjacent muscles, during MVIC compared to TD children. Ninety-four children with CP were prospectively followed for a maximum of 3 years and 7 months during which time they received a maximum of eight injections per muscle of BoNT-A. Outcome measurements included muscle tone and joint range of motion (ROM). BoNT-A injections reduced long-term spasticity in all muscle-groups examined: the gastrocnemius, hamstring, and adductor muscles. Improvement in ROM, however, was only significant after the first injection; after further injections, joint ROM was reduced. Children with CP, under 2 years of age at study start, participated in a randomized trial which compared the effects of one year of early BoNT-A treatment in the gastrocnemius muscle combined with a daily stretching program to a stretching program alone. The effects on ankle and knee ROM, muscle tone in ankle and knee flexors, gross motor function measure (GMFM) and pediatric evaluation of disability inventory (PEDI) were evaluated at one year and at 3.5 years after study commencement. Gait was evaluated with 3D-gait analysis at 5 years of age. Early treatment with BoNT-A significantly increased knee joint ROM and although not significantly, also increased ankle joint dorsiflexion in the BoNT-A group after 1 year. Children in the control group experienced significantly reduced joint ROM at both joint levels at 3.5 years after study commencement. No differences in GMFM or PEDI scores or 3D-gait data were detected comparing the groups.
Conclusions: The activation of muscles differs between children with CP and children with TD when performing a voluntary movement and children with CP express twice as much co-activity. Early BoNT-A intervention in toddlers with CP seems to influence muscle tone and contracture development also after 3.5 years. The effect on gait development remain inconclusive.When BoNT-A treatment in older children (mean age 5.5y at treatment start) is evaluated this suggests that BoNT-A can be effective in reducing muscle tone over a longer period, but not in preventing development of contractures in spastic muscles. The dissociation between the effects on muscle tone and ROM indicates that development of contractures is not coupled to increased muscle tone alone, but might be caused by other mechanisms.
List of papers:
I. Tedroff K, Knutson LM, Soderberg GL (2006). "Synergistic muscle activation during maximum voluntary contractions in children with and without spastic cerebral palsy." Dev Med Child Neurol 48(10): 789-96
Pubmed
II. Tedroff K, Knutson LM, Soderberg GL (2008). "Co-activity during maximum voluntary contraction: a study of four lower-extremity muscles in children with and without cerebral palsy." Dev Med Child Neurol 50(5): 377-81. Epub 2008 Mar 24
Pubmed
III. Forssberg H, Tedroff KB (1997). "Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation?" Dev Med Child Neurol
Pubmed
IV. Tedroff K, Granath F, Forssberg H, Haglund-Åkerlind Y (2009). "Long-term effects of botulinum toxin A in children with cerebral palsy." Developmental Medicine & Child Neurology 51(2): 120-7
Pubmed
V. Tedroff K, Löwing K, Gutierrez-Farewik EM, Haglund-Åkerlind Y, Forssberg H (2009). "Botulinum toxin A treatment in toddlers with cerebral palsy: Effects on muscle tone, contracture development and gait pattern. A randomized controlled trial." (Manuscript)
Fulltext (DOI)
Pubmed
View record in Web of Science®
I. Tedroff K, Knutson LM, Soderberg GL (2006). "Synergistic muscle activation during maximum voluntary contractions in children with and without spastic cerebral palsy." Dev Med Child Neurol 48(10): 789-96
Pubmed
II. Tedroff K, Knutson LM, Soderberg GL (2008). "Co-activity during maximum voluntary contraction: a study of four lower-extremity muscles in children with and without cerebral palsy." Dev Med Child Neurol 50(5): 377-81. Epub 2008 Mar 24
Pubmed
III. Forssberg H, Tedroff KB (1997). "Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation?" Dev Med Child Neurol
Pubmed
IV. Tedroff K, Granath F, Forssberg H, Haglund-Åkerlind Y (2009). "Long-term effects of botulinum toxin A in children with cerebral palsy." Developmental Medicine & Child Neurology 51(2): 120-7
Pubmed
V. Tedroff K, Löwing K, Gutierrez-Farewik EM, Haglund-Åkerlind Y, Forssberg H (2009). "Botulinum toxin A treatment in toddlers with cerebral palsy: Effects on muscle tone, contracture development and gait pattern. A randomized controlled trial." (Manuscript)
Fulltext (DOI)
Pubmed
View record in Web of Science®
Issue date: 2009-01-16
Rights:
Publication year: 2009
ISBN: 978-91-7409-211-0
Statistics
Total Visits
Views | |
---|---|
Children ...(legacy) | 939 |
Children ... | 183 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Children ... | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 2120 |
thesis.pdf | 2020 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 442 |
Sweden | 103 |
China | 69 |
Germany | 49 |
United Kingdom | 21 |
South Korea | 17 |
Russia | 16 |
Turkey | 16 |
Finland | 15 |
Denmark | 9 |
Top cities views
Views | |
---|---|
Ashburn | 52 |
Sunnyvale | 47 |
Beijing | 35 |
Stockholm | 26 |
Kiez | 20 |
Romeo | 20 |
Seoul | 14 |
London | 11 |
Istanbul | 9 |
Mountain View | 9 |